Q&A With Steven Zelenkofske From AstraZeneca: Learning More Lessons From Brilinta And Answering Questions About Statin Guidelines

As more research is done into the effects of Brilinta on patients more is learned about new ways doctors can prescribe the medication to help their patients.

Steven Zelenkofske, DO, from AstraZeneca discussed what new research has been done and what it can mean for patient care during the American Heart Association's annual meeting in Orlando.

In recent years the American Heart Association introduced new guidelines on the proper usage for high intensity statins. While they are not universally implemented there have been signs of progress in this field.